Hledání v detailu akcií
Moje portfolio
Nastavit Oblíbené, nastavit Portfolio
Oblíbené tituly
select
NázevNejlepší
nákup
Nejlepší
prodej
Změna
(%)
ČEZ0,00
KB0,00
PKN82,2682,31-1,45
Msft-1,76
Nokia3,4523,519-3,70
IBM-1,22
Mercedes-Benz Group AG49,2349,245-2,00
PFE0,86
02.08.2025 2:04:00
Indexy online
AD Index online
select
AD Index online
 

  • 01.08.2025 22:00:00
Sotera Health Rg (NASDAQ Cons)
Poslední obchod Změna (%) Změna (USD) Objem obchodů (ks)
11,15 -2,96 -0,34 845 092
R - Real-Time data si mohou aktivovat klienti Patria Plus / Investor Plus ZDE.

 
  • Poslední aktualizace: 03.08.2025
Popis společnosti
Obecné informace
Název společnostiSotera Health Co
TickerSHC
Kmenové akcie:Ordinary Shares
RICSHC.O
ISIN-
Poslední známé roční výsledky31.12.2024
Poslední známé čtvrtletní výsledky31.03.2025
Počet zaměstnanců k 31.12.2024 3 000
Akcie v oběhu k 25.04.2025 283 855 074
MěnaUSD
Konstituent indexůS&P 400 Mid Cap
Kontaktní informace
Ulice9100 South Hills Blvd
MěstoBROADVIEW HEIGHTS
PSČ44147
ZeměUnited States
Kontatní osobaJason Peterson
Funkce kontaktní osobyVice President and Treasurer
Telefon14 402 621 410
Fax13026365454

Business Summary: Sotera Health Company is a global provider of mission-critical end-to-end sterilization solutions and lab testing and advisory services for the healthcare industry. The Company’s segments include Sterigenics, Nordion and Nelson Labs. The Sterigenics business provides outsourced terminal sterilization and irradiation services for the medical device, pharmaceutical, food safety and advanced applications markets using three technologies: gamma irradiation, ethylene oxide (EO) processing and E-beam irradiation. Nordion business is a global provider of Co-60 used in the sterilization and irradiation processes for the medical device, pharmaceutical, food safety, and high-performance materials industries, as well as in the treatment of cancer. In addition, Nordion is a global provider of gamma irradiation systems. Nelson Labs business provides outsourced microbiological and analytical chemistry testing and advisory services for the medical device and pharmaceutical industries.
Financial Summary: BRIEF: For the three months ended 31 March 2025, Sotera Health Co revenues increased 3% to $254.5M. Net loss applicable to common stockholders totaled $13.3M vs. income of $6.3M. Revenues reflect Nordion segment increase of 36% to $32.6M, Sterigenics segment increase of 2% to $169.7M. Net loss reflects Selling/General/Admin Expense increase of 8% to $63.1M (expense), Foreign exchange loss (gain) decrease from $572K (income) to $289K (expense).
Odvětvová klasifikace
TRBC2012Healthcare Facilities & Services (NEC)
MGINDUSTRYBusiness Services
MGSECTORServices
NAICSTesting Laboratories and Services
NAICSMedical Laboratories
NAICSIrradiation Apparatus Manufacturing
NAICSOther Basic Inorganic Chemical Manufacturing
NAICS2007Testing Laboratories
NAICS2007Medical Laboratories
NAICS2007Irradiation Apparatus Mfg
NAICS2007All Other Basic Inorganic Chemical Mfg
NAICS1997Testing Laboratories
NAICS1997Medical Laboratories
NAICS1997Irradiation Apparatus Manufacturing
NAICS1997All Other Basic Inorganic Chemical Manufacturing
SICTesting Laboratories
SICMedical Laboratories
SICX-Ray Apparatus And Tubes
SICIndust'L Inorganic Chemicals, Nec



  • Poslední aktualizace: 03.08.2025
Management společnosti
FunkceJménoVěkVe funkci odVe firmě od
Chairman of the Board, Chief Executive OfficerMichael Petras57
Chief Financial Officer, Senior Vice PresidentJonathan Lyons4726.06.202326.06.2023
President of SterigenicsMichael Rutz53
Senior Vice President, General CounselAlexander Dimitrief6601.11.2022